Condition

Weight Management

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 32 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials32
Recruiting10
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

32 shown
Weight Management After Cancer for Survivors in Rural CommunitiesNCT07426952 · 2026-08-01
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMNCT07667803 · 2026-06-29
RECRUITING
Usability Study of Gestational and Postpartum Weight Management ProgramNCT07272824 · 2025-12-09
RECRUITING
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityNCT07243171 · 2025-11-18
RECRUITING
Advancing Biopsychosocial Care Training InitiativeNCT07049861 · 2025-07-14
RECRUITING
Mitigation of Cardiovascular Disease Risks in Children With Extreme ObesityNCT06967389 · 2025-06-12
RECRUITING
Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary CareNCT07717658 · 2025-02-05
RECRUITING
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body TypesNCT06691100 · 2024-10-16
RECRUITING
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)NCT06562907 · 2024-08-28
RECRUITING
Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With ObesityNCT06809166 · 2024-07-04
RECRUITING
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple DosesNCT07841860 · 2026-09-01
NOT_YET_RECRUITING
A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy ParticipantsNCT06506175 · 2026-07-01
NOT_YET_RECRUITING
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) TrialNCT07505303 · 2026-03-23
ACTIVE_NOT_RECRUITING
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)NCT07073417 · 2025-07-28
ACTIVE_NOT_RECRUITING
GV101 in Healthy Obese ParticipantsNCT06979505 · 2025-06-30
COMPLETED
Ashwagandha Extract for Weight and Stress Management in Overweight and Obese AdultsNCT07215455 · 2025-06-17
COMPLETED
Application-Assisted Weight Management in Endometrial Cancer Fertility PreservationNCT06901778 · 2025-03-31
NOT_YET_RECRUITING
Semaglutide in Treatment of ObesityNCT06604624 · 2024-09-20
COMPLETED
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With ObesityNCT06680440 · 2024-08-26
COMPLETED
A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep ApneaNCT06565871 · 2024-08-01
UNKNOWN
M4C Nutraceutical Intervention Human Health Effects PilotNCT06476236 · 2024-06-17
UNKNOWN
Healthy Lifestyles After Cancer for Adolescents and Young Adults: A Program to Reduce Cardiovascular Risk FactorsNCT05869604 · 2023-12-01
COMPLETED
Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial CancerNCT06312917 · 2023-08-01
COMPLETED
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or ObesityNCT05813795 · 2023-04-05
COMPLETED
Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic PatientsNCT06147752 · 2023-03-28
UNKNOWN
Mindful Eating in Breast Cancer Survivors: A Pilot Study in TürkiyeNCT07007104 · 2022-05-03
COMPLETED
Obesity and Type 2 Diabetes - Raising the Issue of Weight Management in Primary CareNCT03360058 · 2017-10-07
COMPLETED
Satiating Effects of Isolated Soy ProteinsNCT01731197 · 2012-11-01
COMPLETED
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)NCT01511393 · 2012-01-01
ENROLLING_BY_INVITATION
A to Z Study Follow-up: Collection of DNA Data From Buccal SwabsNCT00866151 · 2008-08-01
UNKNOWN
A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body WeightNCT00542009 · 2007-12-01
COMPLETED
Effects of Protein-Enriched Meal on Liver, Kidney or Bone: a Randomized Controlled TrialNCT01030354 · 2004-07-01
COMPLETED

Common interventions

PlaceboDRUG6SemaglutideDRUG2Aerobic ExerciseBEHAVIORAL1ASC30DRUG1Ashwagandha 300 mg standardized root extractDIETARY_SUPPLEMENT1CE-326,597 100 mg QDDRUG1CE-326,597 25 mg QDDRUG1CE-326,597 50 mg QDDRUG1CE-326,597 5mg QDDRUG1Comprehensive Multidisciplinary Obesity CareOTHER1ContraveDRUG1Culinary medicine classesBEHAVIORAL1DEAR weight managementBEHAVIORAL1Diet ProgramBEHAVIORAL1Dry-Blended BeverageDIETARY_SUPPLEMENT1ECC4703DRUG1Ecnoglutide High DosageDRUG1Ecnoglutide Low DosageDRUG1Ecnoglutide Medium DosageDRUG1ecnoglutide tabletsDRUG1Education ControlOTHER1ElecoglipronDRUG1GS-4571DRUG1GV101DRUG1GV101 placeboDRUG1

Trial status mix

COMPLETED12
RECRUITING10
UNKNOWN4
NOT_YET_RECRUITING3
ACTIVE_NOT_RECRUITING2
ENROLLING_BY_INVITATION1

Phase mix

NA13
PHASE27
PHASE15
PHASE34
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.